Biocryst Pharmaceuticals Inc’s recently made public that its Director Hutson Nancy J unloaded Company’s shares for reported $52780.0 on Dec 13 ’24. In the deal valued at $7.54 per share,7,000 shares were sold. As a result of this transaction, Hutson Nancy J now holds 86,638 shares worth roughly $0.71 million.
Then, Hutson Nancy J bought 7,000 shares, generating $52,584 in total proceeds.
Before that, McKee Amy E sold 8,600 shares. Biocryst Pharmaceuticals Inc shares valued at $54,352 were divested by the Director at a price of $6.32 per share. As a result of the transaction, McKee Amy E now holds 27,831 shares, worth roughly $0.23 million.
A number of analysts have revised their coverage, including RBC Capital Mkts’s analysts, who increased its forecast for the stock in mid September from “a Sector perform” to “an Outperform”. Jefferies also remained covering BCRX and has increased its forecast on August 04, 2023 with a “Buy” recommendation from previously “Hold” rating. BofA Securities revised its rating on July 13, 2023. It rated BCRX as “a Buy” which previously was an “a Neutral”.
Price Performance Review of BCRX
On Tuesday, Biocryst Pharmaceuticals Inc [NASDAQ:BCRX] saw its stock jump 3.96% to $8.14. Over the last five days, the stock has gained 8.10%. Biocryst Pharmaceuticals Inc shares have risen nearly 8.24% since the year began. Nevertheless, the stocks have risen 33.66% over the past one year. While a 52-week high of $8.88 was reached on 01/07/25, a 52-week low of $4.03 was recorded on 01/02/25. SMA at 50 days reached $7.64, while 200 days put it at $6.88.
Levels Of Support And Resistance For BCRX Stock
The 24-hour chart illustrates a support level at 7.88, which if violated will result in even more drops to 7.63. On the upside, there is a resistance level at 8.31. A further resistance level may holdings at 8.49. The Relative Strength Index (RSI) on the 14-day chart is 61.55, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.23, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 8.33%. Stochastics %K at 73.71% indicates the stock is a holding.
How much short interest is there in Biocryst Pharmaceuticals Inc?
A steep rise in short interest was recorded in Biocryst Pharmaceuticals Inc stocks on 2024-12-13, dropping by -1.2 million shares to a total of 17.29 million shares. Yahoo Finance data shows the prior-month short interest on 2024-11-15 was 18.49 million shares. There was a decline of -6.95%, which implies that there is a negative sentiment for the stock.
